All | OIS I-III | OIS IV-V | p value | |
---|---|---|---|---|
(n = 66) | (n = 49) | (n = 17) | ||
Age | 10.5 (6.8; 14.1) | 10.9 (6.8; 14.2) | 10.0 (7.1; 13.1) | 0.67 |
Male gender | 43 (65.2) | 32 (65.3) | 11 (64.7) | 0.96 |
Blunt injury | 64 (97.0) | 47 (95.9) | 17 (100) | 1.00 |
ISS | 20.5 (10.0; 33.0) | 17.0 (9.0; 28.0) | 25.0 (17.0; 34.0) | 0.02 |
GCS | 15.0 (14.0; 15.0) | 15.0 (14.0; 15.0) | 15.0 (15.0; 15.0) | 0.16 |
Base excessa | −2.1 (−4.9; −1.1) | −2.4 (−4.7; −0.9) | −2.0 (−5.3; −1.4) | 0.96 |
Lactateb | 2.2 (1.3; 2.9) | 2.3 (1.3; 2.9) | 1.8 (1.4; 2.9) | 0.55 |
Aspartate transaminasec | 302.5 (161.3; 521.0) | 261.0 (145.0; 357.0) | 618.0 (416.5; 969.0) | <0.01 |
Alanine transaminased | 220.0 (120.0; 390.0) | 189.5 (110.8; 266.5) | 461.0 (355.0; 723.0) | <0.01 |
Positive abdominal findings | 45 (68.2) | 29 (59.2) | 16 (94.1) | 0.01 |
Attempted NOM | 60 (90.9) | 45 (91.8) | 15 (88.2) | 0.64 |
Angiographic embolization | 2 (3.0) | 0 (0.0) | 2 (11.8) | 0.06 |
Patients transfused | 14 (21.2) | 10 (20.4) | 4 (23.5) | 0.74 |
ICU LOS | 2.0 (1.0; 5.0) | 2.0 (1.0; 5.0) | 2.0 (1.5; 7.0) | 0.84 |
In-hospital LOS | 7.0 (5.0; 11.3) | 6.0 (5.0; 11.5) | 7.0 (6.0; 13.0) | 0.18 |
Mortality | 2 (3.0) | 1 (2.0) | 1 (5.9) | 0.45 |